Akrivis Technologies

Akrivis is a privately held biotech company founded in 2009 in Cambridge, Massachusetts. Its patented ADAPT™ technology platform delivers a theranostic combination of ultrasensitive in vitro diagnostics, high-resolution imaging and targeted therapeutics. Akrivis, via a French entity, and the CEA-LETI in Grenoble are in final discussions to form a shared R&D laboratory in order to combine their respective ADAPT™ and Lipidot® technologies